Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp
| Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals Inc. |
| BendaRx USA Corp |
| 1:2024cv00395 |
| March 28, 2024 |
| U.S. District Court for the District of Delaware |
| Jennifer L Hall |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 15, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 82
SO ORDERED, re #81 Joint Stipulation and Order of Consolidation with C.A. 23-490-JLH. Signed by Judge Jennifer L. Hall on 4/15/2024. (ceg)
|
| Case associated with lead case: Create association to 1:23-cv-00490-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:23-cv-00490-JLH ONLY. (ceg) |
| Filing 81 Joint STIPULATION and Proposed Order of Consolidation and Statement Pursuant to Rule 81.2 by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Filing 80 NOTICE of Appearance by Karen Elizabeth Keller on behalf of Cephalon, LLC, Teva Pharmaceuticals International GmbH (Keller, Karen) |
| Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb) |
| Filing 79 NOTICE of Appearance by Alexandra M. Joyce on behalf of Eagle Pharmaceuticals Inc. (Joyce, Alexandra) |
| Filing 78 NOTICE of Appearance by Daniel M. Silver on behalf of Eagle Pharmaceuticals Inc. (Silver, Daniel) |
| Filing 77 Local Counsel Letter sent via mail. Notice of Compliance deadline set for 04/29/2024. (mrr) |
| Filing 76 Record of case transferred in from District of Virginia Eastern; Case Number in Other District: 1:23-cv-00788. Copy of Docket Sheet and original file |
|
Filing 75
ORDER granting #73 Joint MOTION to Transfer Case (see Order for further details). Signed by District Judge Rossie D. Alston, Jr on 3/27/2024. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
| Filing 74 Memorandum in Support re #73 Joint MOTION to Transfer Case filed by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 73 Joint MOTION to Transfer Case by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: #1 Proposed Order Proposed Order)(Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 72 STATUS REPORT by Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
|
Filing 71
It is hereby ORDERED that the parties Motion for Extension of Time is granted. The Parties' Joint Status Report shall be due no later than March 19, 2024 re #70 Motion for Extension of Time to File. Signed by District Judge Rossie D. Alston, Jr on 3/13/2024. (Sbro) [Transferred from Virginia Eastern on 3/28/2024.]
|
| Filing 70 MOTION for Extension of Time to Submit Joint Status Report by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: #1 Proposed Order Order)(Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 69 STATUS REPORT Joint Status Report by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 68 STATUS REPORT Joint Status Report by BendaRx USA Corp. (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 67 STATUS REPORT Joint Status Report by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
|
Filing 66
ORDERED that the parties' respective Motions to Seal Exhibit B to Plaintiffs' Memorandum (Dkts. 24, 64) are GRANTED and the redacted portions of Exhibit B shall remain permanently under seal; it is further ORDERED that Plaintiff's Motion to Seal Exhibit A is deemed WITHDRAWN (see Order for further details). Signed by Magistrate Judge William E. Fitzpatrick on 8/29/2023. (Dest) [Transferred from Virginia Eastern on 3/28/2024.]
|
| Filing 65 RESPONSE to Motion re #24 MOTION to Seal Exhibits A and B to Motion to Stay (Defendant's Supplemental Response) filed by BendaRx USA Corp. (Attachments: #1 Exhibit A, #2 Exhibit B (redacted))(Pond, Joshua) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 64 MOTION to Seal by BendaRx USA Corp. (Attachments: #1 Proposed Order)(Pond, Joshua) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 63 Notice of Filing Sealing Motion LCvR5(C) by BendaRx USA Corp re #23 Memorandum in Support,, portions of Exhibit B (Pond, Joshua) [Transferred from Virginia Eastern on 3/28/2024.] |
|
Filing 62
ORDERED that the Consent Motion for Extension of Time to File a Response to Motion to Seal #60 is DISMISSED as moot; it is further ORDERED that Defendant shall file further argument in support of the Motion to Seal #24 , consistent with the requirements of Local Civil Rule 5(C), within seven (7) days of entry of this Order and, if appropriate, an updated redacted version of Exhibit B; it is further ORDERED that Defendant shall file a publicly available version of Exhibit A; it is further ORDERED that Exhibit B shall remain sealed pending a determination by the Court on the Motion to Seal. Signed by Magistrate Judge William E. Fitzpatrick on 8/14/2023. (tran, ) [Transferred from Virginia Eastern on 3/28/2024.]
|
| Filing 61 RESPONSE to Motion re #24 MOTION to Seal Exhibits A and B to Motion to Stay filed by BendaRx USA Corp. (Attachments: #1 Exhibit B (Redacted), #2 Proposed Order)(Pond, Joshua) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 60 Consent MOTION for Extension of Time to File Response/Reply as to #24 MOTION to Seal Exhibits A and B to Motion to Stay by BendaRx USA Corp. (Attachments: #1 Proposed Order)(Pond, Joshua) [Transferred from Virginia Eastern on 3/28/2024.] |
|
Filing 58
ORDER granting #47 Motion to Seal. ORDERED that Dkt. 49 shall remain sealed; it is further ORDERED that Defendant shall submit a response to Plaintiff's Motion to Seal (Dkt. 24), complying with the requirements under Local Civil Rule 7(C), within 7 days of entry of this Order. Signed by Magistrate Judge William E. Fitzpatrick on 07/21/2023. (wgar, ) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 57
ORDERED that the parties shall contact the undersigned's chambers within 14 days of the stay being lifted, to schedule a status conference regarding the adoption of a discovery plan and the entry of a discovery order. Signed by Magistrate Judge William E. Fitzpatrick on 7/21/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 59
Minute Entry for proceedings held before Magistrate Judge William E. Fitzpatrick: Initial Pretrial Conference held on 7/19/2023. Appearance of counsel. Proposed Discovery Plan discussed in open court. Shortly after the IPC, Judge Alston issued an order staying this entire case. Therefore, a Rule 16(b) order will not be issued by Judge Fitzpatrick-per WEF chambers. (Tape #FTR.)(tfitz, ) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 55
ORDER granting #22 Motion to Stay. ORDERED that this matter is STAYED until Final Judgment or order in each of Case Nos. 23-cv-490-CFC (D. Del) and 23-cv-633-CFC (D. Del.). Signed by District Judge Rossie D. Alston, Jr on 07/19/2023. SEE ORDER FOR FURTHER DETAILS. (wgar, ) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 56
ORDER granting #45 Motion for Pro hac vice Appointed Ben Picozzi for Cephalon, LLC,Ben Picozzi for Teva Pharmaceuticals International GmbH. Signed by District Judge Rossie D. Alston, Jr on 7/18/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
| Filing 54 Reply to Motion re #22 MOTION to Stay filed by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: #1 Exhibit X, #2 Exhibit Y)(Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 53 NOTICE of Appearance by Joshua B Pond on behalf of BendaRx USA Corp (Pond, Joshua) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 52 NOTICE by BendaRx USA Corp re #46 Memorandum in Opposition, Corrected Exhibit H to Defendant's Opposition to Plaintiffs' Motion to Stay (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 51 Proposed Joint Discovery Plan by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 50 NOTICE by BendaRx USA Corp re #47 MOTION to Seal Exhibit B to Opposition to Plaintiffs' Motion to Stay (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 49 Sealed Attachment/Exhibit(s) re #47 MOTION to Seal Exhibit B to Opposition to Plaintiffs' Motion to Stay. (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 48 Memorandum in Support re #47 MOTION to Seal Exhibit B to Opposition to Plaintiffs' Motion to Stay filed by BendaRx USA Corp. (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 47 MOTION to Seal Exhibit B to Opposition to Plaintiffs' Motion to Stay by BendaRx USA Corp. (Attachments: #1 Proposed Order)(Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 46 Memorandum in Opposition re #22 MOTION to Stay filed by BendaRx USA Corp. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J)(Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 45 Motion to appear Pro Hac Vice by Ben Picozzi and Certification of Local Counsel Maya Eckstein Filing fee $ 75, receipt number AVAEDC-9019245. by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
|
Filing 44
ORDERED, that Defendant shall file a brief in response to Plaintiffs' Motion to Stay (ECF Nos. 22, 23) by July 12, 2023, and Plaintiffs shall file a reply brief in support of the Motion to Stay by July 17, 2023 in re #41 Consent MOTION to Expedite Briefing Schedule with Respect to Plaintiffs' Motion to Stay. Signed by Magistrate Judge William E. Fitzpatrick on 7/10/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
| Filing 43 STIPULATION re #11 Scheduling Order, by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 42 Notice of Hearing Date set for 7/19/2023 re #22 MOTION to Stay , #23 Memorandum in Support,, (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 41 Consent MOTION to Expedite Briefing Schedule with Respect to Plaintiffs' Motion to Stay by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: #1 Proposed Order Order)(Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 40 NOTICE by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH re #27 Notice of Hearing Date Notice of Withdrawal of Notice of Hearing Date (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 39 Notice of Under Seal Filing LCvR5 (B) by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH re #24 MOTION to Seal Exhibits A and B to Motion to Stay, #25 Memorandum in Support (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 38 Motion to appear Pro Hac Vice by Mark Remus and Certification of Local Counsel Andrew W. Bagley Filing fee $ 75, receipt number AVAEDC-9014072. by BendaRx USA Corp. (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 37 Motion to appear Pro Hac Vice by Shannon Marie Lentz and Certification of Local Counsel Andrew W. Bagley Filing fee $ 75, receipt number AVAEDC-9014003. by BendaRx USA Corp. (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Notice of Correction re #26 Sealed Attachment/Exhibit(s). The filing user has been notified to file a Notice of Under Seal filing LCvR5 (B). (Sbro) [Transferred from Virginia Eastern on 3/28/2024.] |
| Notice of Correction: The filing user has been notified to refile the notice of hearing which requests a Wednesday date in re #27 Notice of Hearing Date. (wgar, ) [Transferred from Virginia Eastern on 3/28/2024.] |
|
Filing 36
ORDER granting #21 Motion for Pro hac vice Appointed Kenneth Schuler for Eagle Pharmaceuticals, Inc. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 35
ORDER granting #20 Motion for Pro hac vice Appointed Alex Grabowski for Eagle Pharmaceuticals, Inc. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 34
ORDER granting #19 Motion for Pro hac vice Appointed Marc Nathan Zubick for Eagle Pharmaceuticals, Inc. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 33
ORDER granting #18 Motion for Pro hac vice Appointed Daniel Brown for Eagle Pharmaceuticals, Inc. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 32
ORDER granting #17 Motion for Pro hac vice Appointed Anne Elise Herold Li for BendaRx USA Corp. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 31
ORDER granting #16 Motion for Pro hac vice Appointed Elise Michelle Baumgarten for Cephalon, LLC,Elise Michelle Baumgarten for Teva Pharmaceuticals International GmbH. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 30
ORDER granting #15 Motion for Pro hac vice Appointed David Issac Berl for Cephalon, LLC,David Issac Berl for Teva Pharmaceuticals International GmbH. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 29
ORDER granting #14 Motion for Pro hac vice Appointed Adam Daniel Harber for Cephalon, LLC,Adam Daniel Harber for Teva Pharmaceuticals International GmbH. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
|
Filing 28
ORDER denying #13 Motion for Pro hac vice. Signed by District Judge Rossie D. Alston, Jr on 7/5/2023. (swil) [Transferred from Virginia Eastern on 3/28/2024.]
|
| Filing 27 Notice of Hearing Date set for 07/14/2023 re #22 MOTION to Stay , #23 Memorandum in Support,, (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 26 Sealed Attachment/Exhibit(s) re #24 MOTION to Seal Exhibits A and B to Motion to Stay. (Attachments: #1 Exhibit Ex.A, #2 Exhibit Ex.B)(Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 25 Memorandum in Support re #24 MOTION to Seal Exhibits A and B to Motion to Stay filed by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 24 MOTION to Seal Exhibits A and B to Motion to Stay by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 23 Memorandum in Support re #22 MOTION to Stay filed by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: #1 Exhibit Ex.A-Under Seal, #2 Exhibit Ex.B.-Under Seal, #3 Exhibit Ex.C, #4 Exhibit Ex.D, #5 Exhibit Ex.E, #6 Exhibit Ex.F, #7 Exhibit Ex.G, #8 Exhibit Ex.L, #9 Exhibit Ex.N, #10 Exhibit Ex.O, #11 Exhibit Ex.P, #12 Exhibit Ex.Q, #13 Exhibit Ex.R, #14 Exhibit Ex.S, #15 Exhibit Ex.T, #16 Exhibit Ex.U, #17 Exhibit Ex.V, #18 Exhibit Ex.W)(Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 22 MOTION to Stay by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 21 Motion to appear Pro Hac Vice by Kenneth Schuler and Certification of Local Counsel Eden Darrell Filing fee $ 75, receipt number AVAEDC-9000599. by Eagle Pharmaceuticals, Inc.. (Darrell, Eden) (Main Document 21 replaced on 6/29/2023) (wgar, ). [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 20 Motion to appear Pro Hac Vice by Alex Grabowski and Certification of Local Counsel Eden Darrell Filing fee $ 75, receipt number AVAEDC-9000591. by Eagle Pharmaceuticals, Inc.. (Darrell, Eden) (Main Document 20 replaced on 6/29/2023) (wgar, ). [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 19 Motion to appear Pro Hac Vice by Marc Zubick and Certification of Local Counsel Eden Darrell Filing fee $ 75, receipt number AVAEDC-9000570. by Eagle Pharmaceuticals, Inc.. (Darrell, Eden) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 18 Motion to appear Pro Hac Vice by Daniel Brown and Certification of Local Counsel Eden Darrell Filing fee $ 75, receipt number AVAEDC-9000550. by Eagle Pharmaceuticals, Inc.. (Darrell, Eden) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 17 Motion to appear Pro Hac Vice by Anne Elise Herold Li and Certification of Local Counsel Andrew W. Bagley Filing fee $ 75, receipt number AVAEDC-8995824. by BendaRx USA Corp. (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 16 Motion to appear Pro Hac Vice by Elise Baumgarten and Certification of Local Counsel Maya Eckstein Filing fee $ 75, receipt number AVAEDC-8995802. by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 15 Motion to appear Pro Hac Vice by David Berl and Certification of Local Counsel Maya Eckstein Filing fee $ 75, receipt number AVAEDC-8995790. by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 14 Motion to appear Pro Hac Vice by Adam Harber and Certification of Local Counsel Maya Eckstein Filing fee $ 75, receipt number AVAEDC-8995779. by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 13 Motion to appear Pro Hac Vice by Ben Picozzi and Certification of Local Counsel Maya Eckstein Filing fee $ 75, receipt number AVAEDC-8995744. by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 12 NOTICE of Appearance by Eden Marie Darrell on behalf of Eagle Pharmaceuticals, Inc. (Darrell, Eden) [Transferred from Virginia Eastern on 3/28/2024.] |
|
Filing 11
SCHEDULING ORDER:Initial Pretrial Conference set for 7/19/2023 at 11:00 AM in Alexandria Courtroom 500 before Magistrate Judge William E. Fitzpatrick.Discovery due by 10/13/2023.Final Pretrial Conference set for 10/19/2023 at 10:00 AM in Alexandria Courtroom 1000 before District Judge Rossie D. Alston Jr. Signed by District Judge Rossie D. Alston, Jr on 06/22/2023. (Attachments: #1 Magistrate Consent Form, #2 Pretrial Notice)(tran) [Transferred from Virginia Eastern on 3/28/2024.]
|
| Filing 9 ANSWER to Complaint by BendaRx USA Corp.(Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 8 Financial Interest Disclosure Statement (Local Rule 7.1) by BendaRx USA Corp. (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 7 NOTICE of Appearance by Andrew W. Bagley on behalf of BendaRx USA Corp (Bagley, Andrew) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 6 NOTICE by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH re #1 Complaint, Report onthe filing or Determination of an Action regarding a Patent or Trademark (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 5 Summons Issued as to BendaRx USA Corp, NOTICE TO ATTORNEY: Please remove the headers and print two duplexed copies of the electronically issued summons for each Defendant. Please serve one copy of the summons and a copy of the Complaint upon each Defendant. Please ensure that your process server returns the service copy (executed or unexecuted) to your attention and electronically file it using the filing events, Summons Returned Executed or Summons Returned Unexecuted. (Attachments: #1 Notice to Attorney)(Sbro) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 4 Corporate Disclosure Statement by Eagle Pharmaceuticals, Inc.. (Darrell, Eden) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 3 Proposed Summons re #1 Complaint, by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Eckstein, Maya) (Main Document 3 replaced to correct summons on 6/20/2023) (Sbro). [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 2 Financial Interest Disclosure Statement (Local Rule 7.1) by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
| Filing 1 Complaint ( Filing fee $ 402, receipt number AVAEDC-8986443.), filed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, LLC. (Attachments: #1 Civil Cover Sheet Civil Cover Sheet, #2 Exhibit Ex.A, #3 Exhibit Ex.B, #4 Exhibit Ex.C, #5 Exhibit Ex.D, #6 Exhibit Ex.E, #7 Exhibit Ex.F, #8 Exhibit Ex.G, #9 Exhibit Ex.H, #10 Exhibit Ex.I, #11 Exhibit Ex.J, #12 Exhibit Ex.K)(Eckstein, Maya) [Transferred from Virginia Eastern on 3/28/2024.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
